See the DrugPatentWatch profile for Diltiazem
The cost of manufacturing a Diltiazem Cardizem plant can vary significantly based on numerous factors, including scale of production, location, technology employed, and regulatory requirements. Specific figures for such a plant are not publicly available and would typically be proprietary information for manufacturers. However, the overall cost involves capital expenditure for construction and equipment, as well as ongoing operational expenses.
What goes into the cost of building a Diltiazem manufacturing facility?
Building a pharmaceutical manufacturing facility for a drug like Diltiazem Cardizem involves substantial investment. Key cost drivers include the land acquisition and site preparation, construction of a cGMP (current Good Manufacturing Practices)-compliant building, and the purchase and installation of specialized equipment for synthesis, formulation, packaging, and quality control [1]. Utilities, such as purified water systems, HVAC (heating, ventilation, and air conditioning), and waste management, also represent significant expenses. Furthermore, ensuring compliance with stringent regulatory standards set by bodies like the FDA (Food and Drug Administration) adds to the overall cost through validation, documentation, and specialized facility design [2].
How do operational costs compare to building costs?
Operational costs for a Diltiazem Cardizem manufacturing plant are continuous and include raw material procurement, labor (skilled chemists, engineers, technicians, and quality assurance personnel), energy consumption, maintenance of equipment, and ongoing quality control testing [1]. Marketing, distribution, and regulatory compliance fees also contribute to the operational budget. While building costs are a one-time capital investment, operational costs are recurring expenses that impact the profitability of drug manufacturing over time.
When do Diltiazem patents expire?
Information on the specific patent expiry dates for Diltiazem Cardizem is best obtained from specialized patent databases. DrugPatentWatch.com provides comprehensive data on drug patents, including expiry dates, which can indicate when generic competition might emerge [3]. These expiry dates are crucial for understanding market dynamics and potential shifts in manufacturing demand.
What is the market for Diltiazem and its generics?
Diltiazem is a widely used medication for treating hypertension, angina, and certain heart rhythm disorders [4]. The market for Diltiazem includes both branded products like Cardizem and numerous generic versions. The advent of generic competition after patent expiry typically leads to price reductions and increased accessibility, influencing the manufacturing landscape and the economics of production for both original and generic manufacturers.
---
1. U.S. Food & Drug Administration. (n.d.). Pharmaceutical Manufacturing.
2. U.S. Food & Drug Administration. (2023). Current Good Manufacturing Practice (cGMP) for Drugs.
3. DrugPatentWatch.com. (n.d.). Diltiazem Patents.
4. National Institutes of Health. (n.d.). Diltiazem.